Highly Integrated Nanoplatform Based on an E-Selectin-Targeting Strategy for Metastatic Breast Cancer Treatment
Abstract:
Therapeutic goals for metastatic breast cancer, including shrinkage of established metastasis and suppression of movement of tumor cells, are often hard to achieve and remain the main obstacles restricting the antimetastatic efficacy of targeted drug delivery systems (TDDSs). Herein, we proposed an E-selectin-targeting nanoplatform for the systemic treatment of metastatic breast cancer. Versatile functions, including killing the circulating tumor cells, shrinking the established lesions, as well as inhibiting the movement of tumor cells, were integrated into doxorubicin-loaded sialic acid-dextran-octadecanoic acid (SDO) micelles (SDD). The prepared SDD micelles could not only inhibit lung and liver metastasis in the orthotopic 4T1 tumors model, but also decrease the metastatic lesions in the metastatic 4T1 cell model, resulting in 27.33% reduced number of metastatic nodules when compared to those without sialic acid modification. It was found that the good antimetastatic effect of SDD was only partially attributed to its ability on removing metastatic cells and metastases. Most importantly, the blank SDO micelles left in the lesion could further inhibit the cell migration and cell-cell binding. These results suggest that SA-driven TDDS has the potential for specific targeting and effective treatment of cancer metastasis.
Insights
This study introduces a novel E-selectin-targeting nanoplatform for metastatic breast cancer treatment. The developed micelles effectively inhibit metastasis and reduce metastatic nodules by targeting tumor cells and their migration.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Metastatic breast cancer treatment faces challenges in shrinking tumors and preventing cell spread.
- Targeted drug delivery systems (TDDSs) show promise but require enhanced antimetastatic efficacy.
- Overcoming metastasis remains a critical therapeutic goal in breast cancer management.
Purpose of the Study:
- To develop and evaluate an E-selectin-targeting nanoplatform for systemic treatment of metastatic breast cancer.
- To investigate the antimetastatic capabilities of doxorubicin-loaded sialic acid-dextran-octadecanoic acid (SDO) micelles.
- To assess the dual function of drug delivery and inhibition of tumor cell migration by the nanoplatform.
Main Methods:
- Preparation of doxorubicin-loaded SDO micelles (SDD) with E-selectin targeting.
- Evaluation of SDD micelle efficacy in orthotopic 4T1 and metastatic 4T1 tumor models.
- Assessment of inhibition of lung and liver metastasis, and reduction of metastatic nodules.
- Investigation of the role of blank SDO micelles in inhibiting cell migration and cell-cell binding.
Main Results:
- SDD micelles demonstrated significant inhibition of lung and liver metastasis in vivo.
- A 27.33% reduction in metastatic nodules was observed compared to non-sialic acid modified micelles.
- Blank SDO micelles exhibited a crucial role in suppressing tumor cell migration and cell-cell binding.
- The nanoplatform showed a dual mechanism involving drug delivery and intrinsic antimetastatic properties.
Conclusions:
- Sialic acid-driven TDDS, specifically SDD micelles, offers potential for targeted treatment of breast cancer metastasis.
- The nanoplatform effectively shrinks established lesions and suppresses tumor cell movement.
- This approach holds promise for improving therapeutic outcomes in metastatic breast cancer by addressing key obstacles.
Related Concept Videos
Selectins
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Persuasion Strategies
Definite Integral


